Pacer Advisors, Inc. Stoke Therapeutics, Inc. Transaction History

Pacer Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$11.03 - $17.52 $5,007 - $7,954	454 New	454 $6,000
Q2 2021 Jul 21, 2021	SELL	$30.53 - $41.09 $24,759 - $33,323	-811 Closed	0 $0
Q1 2021 Apr 05, 2021	BUY	$36.08 - $69.81 $13,854 - $26,807	384 Added 89.93%	811 $31,000
Q4 2020 Jan 20, 2021	BUY	$33.62 - $61.93 $14,355 - $26,444	427 New	427 $26,000

125

57.6M

9.3K

35.2K

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $367M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.